Subscribe

Mary Beth Nierengarten

Articles by Mary Beth Nierengarten

Doublet Chemo Proves Superior to Single-agent Therapy in Older Patients with Advanced Non-small-cell Lung Cancer

ByMary Beth Nierengarten

August 9th 2010

Data from French trial should inform treatment decisions in the majority of lung cancer patients aged 70 and up.

Latest Updated Articles

Doublet Chemo Proves Superior to Single-agent Therapy in Older Patients with Advanced Non-small-cell Lung Cancer
Published: August 9th 2010 | Updated:

Trending on CGTlive®

Rutgers and Iovance Assess E7 TCR T-Cell Therapy in Phase 1/2 Trial for HPV-Associated Tumors

Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA

CGTLive®’s Weekly Rewind – December 19, 2025

The Implications of the Final Data From Hemgenix’s HOPE-B Trial